| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.13 (Miss by $-0.64) |
| EPS GAAP Actual | $0.13 (Miss by $-0.64) |
| Revenue Actual | $55336.5B |
| Revenue Surprise | Beat by $55336500M |
| Announce Date | 03/27/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.5 |
| EPS GAAP Estimate | $0.5 |
| Revenue Estimate | $0.06774B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 0.10126 | 185.07 | 0.10126 | 0.10126 | 0 |
| Dec 2026 | 0.10126 | 185.07 | 0.10126 | 0.10126 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0953 | -0.6747 | 55336.5B | -28.8% | 55336426.59M |
| FQ2 2025 (Jun 2025) | 0.56 | 0.02 | 0.0701641B | -104258203.04% | 1.29M |
| FQ1 2025 (Mar 2025) | 0.32 | 0.32 | 63312.8B | -7.29% | 63312800M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.0153606B | 100% | 15.36M |
| FQ3 2024 (Sep 2024) | -2465840 | -2465840 | 71274.8B | 100% | 71274800M |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 73151.9B | 100% | 73151900M |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 67929.1B | 100% | 67929100M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
03/27/2026 (Pre-Market)
Consensus EPS Estimates
0.5
Consensus Revenue Estimates
0.06774B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.5 | -- | 0.5 | 0.5 | 1 |
| FQ3 2026 (Sep 2026) | 0.89 | 89.29 | 0.89 | 0.89 | 1 |
| FQ2 2026 (Jun 2026) | 0.67 | 16.42 | 0.67 | 0.67 | 1 |
| FQ1 2026 (Mar 2026) | 0.5 | 36 | 0.5 | 0.5 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.07B | -- | 0.07B | 0.07B | 1 |
| FQ3 2026 (Sep 2026) | 0.08B | -70447385.68 | 0.08B | 0.08B | 1 |
| FQ2 2026 (Jun 2026) | 0.07B | 4.78 | 0.07B | 0.07B | 1 |
| FQ1 2026 (Mar 2026) | 0.07B | -93464322.79 | 0.07B | 0.07B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.77 | 0.0953 | -0.6747 | -707.97% |
| FQ2 2025 (Jun 2025) | 0.54 | 0.56 | 0.02 | 3.57% |
| FQ1 2025 (Mar 2025) | 0.32 | 0.32 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | -2465840 | -2465840 | 100% | |
| FQ2 2024 (Jun 2024) | 0.56 | 0.56 | 100% | |
| FQ1 2024 (Mar 2024) | 0.31 | 0.31 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.07B | $55336.5B | $55336426.59M | 100% |
| FQ2 2025 (Jun 2025) | $0.07B | $0.07B | $1.29M | 1.84% |
| FQ1 2025 (Mar 2025) | $0B | $63312.8B | $63312800M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.02B | $15.36M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $71274.8B | $71274800M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $73151.9B | $73151900M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $67929.1B | $67929100M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |